Explore Current Needs:


If you have an opportunity that matches one of our Current Needs, we invite you to submit some basic information for our review. We'll respond to your submission within 1 week. If you have another innovative consumer healthcare solution, please browse our GSK Consumer Health Focus Areas and contact us with opportunities you think may be a good fit for GSK Consumer Healthcare.

SKIN HEALTH TECHNOLOGIES

From birth through to old age, skin changes and adapts and is subject to numerous challenges. As such it requires the right maintenance to keep it healthy. Therefore we are looking for technologies at different life stages. And technologies that work naturally with skin to repair the barrier and makes skin less sensitive.

SENSITIVE SKIN

We are seeking collaborative development opportunities of novel technologies that are designed for sensitive skin. We would welcome new technologies that are designed for consumers with sensitive skin or collaborative relationships across academia, industry or SME that further enable the understanding of sensitive skin.

NEW ACNE SOLUTIONS

We are seeking new approaches suitable for sensitive easily irritated skin for mild to moderate acne that are superior or parity to current technologies.  Helping to provide skin with a highly effective solution but protecting the skin barrier and being mild and caring.

DIGITAL HEALTH PLATFORMS

We are interested in connected devices which help consumers manage their Respiratory conditions.  Areas of interest broadly include diagnostics, medication compliance and symptom tracking for our Multi-symptom, Allergy, Decongestion and Smokers’ Health franchises.

DIFFERENTIATED ORAL DOSAGE FORMS

We are seeking differentiated oral dosage forms for our Multi-symptom, Allergy and Smokers’ Health franchises.  This innovation may deliver superior efficacy or enhanced user experience. Minimum data requirement = proof of concept.

NASAL SPRAY DELIVERY

We are interested in innovation related to delivery of OTC medicines into the nasal cavity for our Allergy and Decongestion franchise.  This innovation may deliver superior efficacy or enhanced user experience due to unique ingredients/formulations or device design. Minimum data requirement = proof of concept.

Next-Generation Nicotine Replacement Transdermal Technology

We are interested in innovative transdermal patch, topical, or device technologies that can provide superior nicotine delivery compared to currently marketed transdermal nicotine delivery patches.

New Plaque-Reducing or Plaque-Inhibiting Solutions

The buildup of dental plaque is the precursor for several oral diseases, including gum disease. In the early stages, this can lead to soreness, inflammation and bleeding of the gums on brushing. Therefore, we are seeking to develop products that help reverse the early signs of gum disease and prevent it from recurring.

To achieve this, we are seeking opportunities that reduce or inhibit the attachment of plaque to oral surfaces or that break up existing plaque without the need for antimicrobials. Ideally, these ingredients can be incorporated into a mouthwash or toothpaste, but other formats would also be considered.

Long-Lasting Efficacy for Oesophageal Reflux Management

We are interested in products/technologies with clinical evidence for effectively managing the occurrence (frequency) and symptoms (severity) of oesophageal reflux and for providing consequential improvements in quality of life. We would like to see products with novel approaches or modes of action.

Skin Cleansing Solutions

We are seeking technical approaches to gently and effectively cleanse sensitive easily irritated, fragile skin. These cleansers should be designed to respect and maintain skin barrier function.

Novel Packaging Solutions – Pain Relief

We are interested in novel packaging solutions that are more efficient or easier for the consumer to use (eg, packages for the arthritic hands) or that are safer (eg, child-resistant).

Temporal and Efficacy Aspects – PAIN RELIEF

The consumer in pain needs an analgesic solution that works quickly and effectively, so any formulation technologies that enable a quicker onset of pain relief or that extend the duration of relief are of interest to us. We are also interested in technologies that provide the same pain relief at a lower dose.

Lower Digestive Health Solutions

We are interested in technologies that address common digestive disorders and/or manage their associated symptoms (eg, food intolerance, irritable bowel syndrome, constipation).

New or Improved Formats – PAIN RELIEF

Any solution that represents a benefit for the consumer in pain interests us. For example, what is the next soft gel thin film, or orally disintegrating tablet?

Technologies for Sugar Reduction

We are interested in commercially available or close-to commercialisation technologies to address sugar reduction in food products—including liquids, powder beverages and cereals—while maintaining the sensory attributes of these products. These technologies might modulate sugar release or reduce sugar in other ways.

Posology – PAIN RELIEF

In general, the less onerous a dosing regimen is, the greater the probability of consumer compliance. As such, we are interested in technologies that provide similar pain relief with a more convenient regimen.

Manufacturing TECHNOLOGIES

We seek manufacturing technologies that enable more efficient, lower cost production or new and improved formats that offer potential benefits in drug delivery (eg, 3D printing).

Natural Pain Relief Solutions

The evolution of natural solutions—such as glucosamine and/or chondroitin for cartilage maintenance, avocado soy unsaponifiables for osteoarthritis and butterbur for migraines— is interesting and potentially attractive provided there is a solid scientific and clinical basis established. In general, we are open to exploring natural solutions that (a) have a coherent scientific rationale and associated data package and (b) provide some added benefit in pain relief when used alone or in combination with an active pharmaceutical ingredient (eg, acetaminophen or paracetamol + caffeine).

Pain Relief Devices and “Non-Traditional” Solutions

One of the more active areas in pain innovation is the evolution of devices and digital technologies (eg, TENS) that purport to treat, objectively measure, sense and predict pain (eg, migraine episodes) and that provide biomechanical feedback to the consumer. These innovations are of interest to us provided they have a solid scientific rationale and associated data package and truly represent an advantage for the consumer in pain.

Novel Packaging Solutions - PAIN RELIEF

We are interested in novel packaging solutions that are more efficient or easier for the consumer to use (eg, packages for the arthritic hands) or that are safer (eg, child-resistant).

Digital Health Solutions

We’re interested in technologies such as wearables, mobile medical apps, novel sensors, connected medical devices, machine learning algorithms and other digital health tools for consumers in four key areas:

  • Medication adherence
  • Health and symptom tracking
  • Diagnosis/self-selection
  • Treatment

The goal is for these technologies to complement the OTC products in our established categories: Pain Relief, Oral Health, Respiratory, Nutrition/Digestive Health and Skin Health.

To develop these digital health technologies, we seek partners for licensing and co-development. We’re primarily seeking patent-protected innovations in early- or late-stage development.

Lip Health Solutions

A cold sore outbreak causes small blisters or sores on or around the lips. With treatment cold sores typically heal within 2-3 weeks, but the herpes virus remains. This virus can then reactivating causing a reoccurrence of the sore. For consumer this can impact overall wellbeing and confidence.

As such, we would like to identify:

  • Faster, better solutions for cold sore management before, during and after the cold sore episode
  • Novel ways to mask the cold sore completely
  • Identify ways to enable consumers to treat the cold sore to prevent the blister phase
  • Clinically proven post-phase 2 technologies seeking partners for further development
  • Develop solutions for application compliance of the treatment, and enable better delivery of the active. This could be novel dispensing and application solutions (e.g. Packaging) and solutions that increase cues for compliance and dosing application

Skin Lightening Technologies

We are seeking novel technologies to deliver superior skin lightening/fairness/even tone that are fast-acting and non-irritating, without whitening the skin through opacifiers and tints. These technologies have to be proven to deliver improved skin appearance.

ANTI-AGEING INNOVATIONS

We want to identify novel technologies to address skin ageing. These could be aesthetically superior UV protection products (with specific interest in UVA:UVB 1:1 technologies/products); Improved wrinkle appearance and technologies that do that without increasing sensitivity or irritation in skin. Technologies to address other ageing parameters i.e. age spot, damage to fragile / thin skin from tearing.

Relief for Dry Skin and Optimisation of Skin Barrier Function

We are seeking collaborative development of novel technologies to improve skin barrier function. Addressing skin need to help with sensitivity, atopic dermatitis based conditions and the impairment caused by intrinsic and extrinsic factors (such as pollutants and irritants).

Gum Health

Sodium bicarbonate is an ingredient in various toothpastes to help tackle early-stage gum disease (gingivitis) and maintain healthy gums. However, when present in high concentrations, sodium bicarbonate gives the toothpaste a very strong, salty taste which results in low acceptability by consumers.

We are seeking solutions to mask the salty taste in toothpastes with high concentrations of sodium bicarbonate, so that this acceptance barrier is overcome and consumers can benefit from these products.

Enamel Health

Teeth are subject to numerous challenges throughout the day from dietary sugars, acids and bacteria. Despite the use of fluoridated toothpaste and mouthwash, all of these factors have contributed to a significant rise in the number of fillings, enamel wear and sensitivity.

Therefore we are seeking solutions that would protect tooth enamel from these challenges and/or repair the damage that has been caused.

Anti-Fungal Technologies

There are many commercially available nail lacquers, creams and topical solutions that offer onychomycosis (nail fungus) treatments. The different products are based on different technologies; however, they all share a common downside: a prolonged and lengthy application regimen (often up to a year). This generally results in a poor overall resolution of the fungal infection.

Therefore, we are seeking anti-fungal treatment technologies that deliver faster, quicker better solutions for nail fungal infections. These solutions would be expected to deliver a step change versus the current market solutions across a number of areas (for example- consumer experience, active delivery and time to cure). Delivery mechanisms can be novel formats, actives and novel delivery systems and devices.

Denture Cleansers

Denture cleansers are used to clean dentures when they are out of the mouth. They kill microorganisms and remove stains. Microorganisms can cause bad breath and denture-related infections. Denture cleansers may be used with brushing and they must not damage the denture.

The vast majority of denture cleansers are tablet formats based on bleaching technologies. A limited number of denture-cleaning pastes, liquids and powders exist.

Maintaining clean dentures, free from stains and bacteria, takes several steps in the bathroom routine and can be perceived as onerous by the consumer. A great improvement for consumer experience would be to have a highly efficient cleanser that would make denture care easier.

We are seeking solutions for alternative cleanser technologies that are more consumer-friendly but still meet or exceed the performance and safety of commercially available denture cleanser tablets.

Anti-Itch Technologies

Itchy, irritated skin is a significant issue that can impact consumer wellbeing and quality of life. It can be a hallmark of atopic dermatitis, skin allergy-but also skin irritation from the number of exogenous factors such as the environment, insect bites and other triggering factors. Overall, resulting in inflamed skin.

As such we are seeking topical or systemic therapeutic solutions to help relieve itch, allergy and skin inflammation (Eczema-prone, red, dry, itchy and flaky skin). Essentially, helping and supporting the management of a skin inflammation response. Delivery mechanisms such as novel formats (patches), actives and devices would be of interest.

Denture Adhesive

There are many commercially available denture adhesives based on pastes, powders or adhesive pads that may be placed on dentures to help them stay in place. The different products are based on different technologies; however, all share a common downside: an unpleasant sensorial experience and discomfort to the consumers. This unpleasant sensorial experience during use can be a result of:

  • Chemical taste
  • Overflow of the product from the edges of the denture
  • Phase separation of the formulation, leading to a grainy or gritty texture
  • Oil/greasy products leaving an oily sensation in the mouth
  • The hard-to-remove product residue left behind in the mouth when the denture is taken out

Therefore, we are seeking solutions to improve consumers’ sensorial, in-mouth experience of using denture adhesives, while maintaining the fixative properties throughout the day.